Used primarily in pharmaceutical research, 4-(trifluoromethyl)imidazolidin-2-one serves as a key intermediate in the synthesis of various bioactive compounds. Its trifluoromethyl group enhances the metabolic stability and lipophilicity of drug candidates, making it valuable in developing treatments for central nervous system disorders and other therapeutic areas. Additionally, it is employed in agrochemical research to create novel pesticides and herbicides, leveraging its unique chemical properties to improve efficacy and environmental safety.